Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
ખોલો
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.21%
1,091.51
-2.30
-0.21%
—1,093.811,096.521,100.221,091.51——
SIXC
Communications
SIXC
Communications
SIXC
+0.22%
610.11
+1.34
+0.22%
—608.77608.77612.97608.77——
SIXE
Energy
SIXE
Energy
SIXE
-1.34%
1,237.98
-16.83
-1.34%
—1,254.811,253.011,253.871,226.33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.93%
1,744.71
-16.40
-0.93%
—1,761.111,764.271,766.881,744.71——
SIXM
Financials
SIXM
Financials
SIXM
-0.37%
640.18
-2.40
-0.37%
—642.58644.87648.48640.18——
SIXR
Staples
SIXR
Staples
SIXR
-0.18%
849.58
-1.55
-0.18%
—851.13855.66858.75845.56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.23%
217.48
-0.50
-0.23%
—217.98217.98218.65216.88——
SIXT
Technology
SIXT
Technology
SIXT
+1.52%
3,260.69
+48.86
+1.52%
—3,211.833,227.213,268.383,226.55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.69%
942.45
-6.53
-0.69%
—948.98948.58957.83941.97——
SIXV
Health care
SIXV
Health care
SIXV
-0.52%
1,466.80
-7.72
-0.52%
—1,474.521,479.031,481.041,466.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.22%
2,397.50
+5.38
+0.22%
—2,392.122,396.952,421.222,382.32——
SNW:ETR
Sanofi SA
€79.82
+2.03%
(+1.59) 1D
30 એપ્રિલ, 05:35:38 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for SNW...
ખોલો
€78.31
High
€80.10
Low
€78.00
Mkt. cap
૯૬.૩૬ અબજ
Avg. vol.
૧૮.૬૫ હજાર
Volume
૨૪.૦૫ હજાર
P/E ratio
૧૨.૯૧
52-wk high
€98.27
52-wk low
€74.92
EPS
€6.18
Shares outstanding
૧.૨૫ અબજ
No. of employees
૭૫ હજાર
News stories
From sources across the web
પ્રોફાઇલ
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in the Forbes Global 2000 was 89. Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
About Sanofi SA
CEOપોલ હડસન
Employees74.8 હજાર
Founded1973
Headquartersપૅરિસ, Île-de-France, ફ્રાંસ
Sector-
Websitesanofi.com
Last report
23 એપ્રિલ, 2026
Fiscal Period
Q1 2026
Normalized EPS / Estimate
૧.૮૮/ (૧.૮૦ est.)EUR
+4.50%beat
Revenue / Estimate
૧૧.૨૪ અબજ/ (૧૦.૨૩ અબજ est.)EUR
+9.96%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
જૂન 2025
સપ્ટે 2025
ડિસે 2025
માર્ચ 2026
Revenue
10.74 અબજ
13.17 અબજ
12.20 અબજ
11.24 અબજ
Cost of goods sold
2.99 અબજ
3.41 અબજ
3.63 અબજ
3.06 અબજ
Cost of revenue
2.99 અબજ
3.41 અબજ
3.63 અબજ
3.06 અબજ
Research and development expenses
1.91 અબજ
1.83 અબજ
2.29 અબજ
1.75 અબજ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.32 અબજ
2.29 અબજ
2.82 અબજ
2.33 અબજ
Operating expense
6.03 અબજ
5.97 અબજ
6.84 અબજ
5.94 અબજ
Total operating expenses
9.02 અબજ
9.39 અબજ
10.46 અબજ
9.00 અબજ
Operating income
1.71 અબજ
3.78 અબજ
1.74 અબજ
2.25 અબજ
Other non operating income
-2.40 કરોડ
-
12.20 કરોડ
-4.00 કરોડ
EBT including unusual items
1.47 અબજ
3.51 અબજ
-1.16 અબજ
2.01 અબજ
EBT excluding unusual items
1.74 અબજ
3.67 અબજ
1.70 અબજ
2.14 અબજ
Income tax expense
23.00 કરોડ
68.00 કરોડ
-34.80 કરોડ
42.00 કરોડ
Effective tax rate
15.68%
19.38%
30.13%
20.85%
Other operating expenses
1.42 અબજ
1.39 અબજ
1.19 અબજ
1.33 અબજ
Net income
3.94 અબજ
2.80 અબજ
-80.10 કરોડ
1.61 અબજ
Net profit margin
36.70%
21.28%
-6.56%
14.35%
Earnings per share
-
-
1.53
1.88
Interest and investment income
7.20 કરોડ
11.40 કરોડ
7.90 કરોડ
6.00 કરોડ
Interest expense
-6.20 કરોડ
-22.70 કરોડ
-
-13.80 કરોડ
Net interest expenses
1.00 કરોડ
-11.30 કરોડ
7.90 કરોડ
-7.80 કરોડ
Depreciation and amortization charges
-
-
-
-
EBITDA
2.48 અબજ
4.20 અબજ
3.49 અબજ
2.78 અબજ
Gain or loss from assets sale
-26.60 કરોડ
26.60 કરોડ
-7.90 કરોડ
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer